Related Experiment Video
Updated: May 2, 2026

A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model
Published on: June 4, 2021
The role of tissue plasminogen activator use and systemic hypercoagulability in central line-associated bloodstream
Kinna Thakarar1, Matthew Collins2, Lana Kwong3
1Section of Infectious Diseases, Boston Medical Center, Boston, MA.
Background:
Central line-associated bloodstream infections (CLABSIs) impact patient outcomes and increase cost of hospitalization. In situ thrombus is known to promote microbial adhesion and colonization and potentially lead to CLABSI. Clinical validation of this theory, adjusting for presence of systemic hypercoagulability, is needed.
Methods:
This study is a retrospective review of all adult and pediatric patients with peripherally inserted central catheter placement over a 4-year period at our tertiary care center. Tissue plasminogen activator (TPA) use was utilized as indicator for line site thrombus. CLABSIs rates were compared in patients with or without TPA use, adjusting for the presence of hypercoagulable conditions, age, and severity of illness.
Results:
A total of 3,723 patients with peripherally inserted central catheter lines was evaluated, 40% of whom received TPA. The adjusted odds of developing a CLABSI was 3.59 times greater in those patients who received TPA compared with those who did not (95% confidence interval [CI]: 1.86-6.94). Neither severity of illness (odds ratio [OR], 1.00; 95% CI: 0.51-1.96) nor primary (OR, 3.41; 95% CI: 0.43-26.7) or secondary hypercoagulability (OR, 0.91; 95% CI: 0.44-1.88) were statistically associated with a higher risk of infection.
Conclusion:
The use of TPA, as a possible indicator in situ thrombus, was associated with a higher risk of developing CLABSI. Neither primary nor secondary hypercoagulability was correlated with risk of developing CLABSI.
More Related Videos
09:57A Protocol to Set Up Needle-Free Connector with Positive Displacement on Central Venous Catheter in Intensive Care Unit
Published on: July 13, 2019
05:51Computed Tomography (CT) Guided Implantation of a Totally Implantable Venous Access Port (TIVAP) through Subclavian Vein
Published on: January 13, 2026
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Venous Thrombosis I: Introduction
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
Clot Retraction and Fibrinolysis